disopyramide has been researched along with Tachycardia, Ventricular in 16 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Monomorphic sustained ventricular tachycardia (MSVT) was revisited in relation to the electrophysiologic findings and their relation to the drug efficacy." | 2.40 | Reentrant ventricular tachycardia. Interpretations of electrophysiologic findings and its applications. ( Aizawa, Y; Tanabe, Y; Yamaura, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (62.50) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Rowin, EJ | 1 |
| Sridharan, A | 1 |
| Madias, C | 1 |
| Firely, C | 1 |
| Koethe, B | 1 |
| Link, MS | 1 |
| Maron, MS | 1 |
| Maron, BJ | 1 |
| Perrin, T | 1 |
| Guieu, R | 1 |
| Koutbi, L | 1 |
| Franceschi, F | 1 |
| Hourdain, J | 1 |
| Brignole, M | 1 |
| Deharo, JC | 1 |
| Mizobuchi, M | 1 |
| Enjoji, Y | 1 |
| Yamamoto, R | 1 |
| Ono, T | 1 |
| Funatsu, A | 1 |
| Kambayashi, D | 1 |
| Kobayashi, T | 1 |
| Nakamura, S | 1 |
| Takada, Y | 1 |
| Isobe, S | 1 |
| Okada, M | 1 |
| Ando, A | 1 |
| Nonokawa, M | 1 |
| Inden, Y | 1 |
| Tomita, Y | 1 |
| Suzuki, A | 1 |
| Hirai, M | 1 |
| Murohara, T | 1 |
| Komori, S | 1 |
| Sano, S | 1 |
| Li, BH | 1 |
| Matsumura, K | 1 |
| Naitoh, A | 1 |
| Mochizuki, S | 1 |
| Ishihara, T | 1 |
| Watanabe, A | 1 |
| Umetani, K | 1 |
| Ijiri, H | 1 |
| Awaji, T | 1 |
| Hashimoto, K | 1 |
| Fiksinski, E | 1 |
| Martin, D | 1 |
| Venditti, F | 1 |
| Makkar, RR | 1 |
| Fromm, BS | 1 |
| Steinman, RT | 1 |
| Meissner, MD | 1 |
| Lehmann, MH | 1 |
| Ogawa, S | 2 |
| Mitamura, H | 2 |
| Katoh, H | 1 |
| Miyazaki, T | 1 |
| Miyoshi, S | 1 |
| Soejima, K | 1 |
| Aizawa, Y | 5 |
| Ebe, K | 1 |
| Shibata, A | 2 |
| Chinushi, M | 2 |
| Naitoh, N | 1 |
| Ogawa, Y | 1 |
| Shiba, M | 1 |
| Takahashi, K | 1 |
| Tanabe, Y | 1 |
| Yamaura, M | 1 |
| Watanabe, T | 1 |
| Yamaki, M | 1 |
| Tachibana, H | 1 |
| Yamauchi, S | 1 |
| Kubota, I | 1 |
| Tomoike, H | 1 |
| Granowitz, EV | 1 |
| Tabor, KJ | 1 |
| Kirchhoffer, JB | 1 |
3 reviews available for disopyramide and Tachycardia, Ventricular
| Article | Year |
|---|---|
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramid | 1993 |
Reentrant ventricular tachycardia. Interpretations of electrophysiologic findings and its applications.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Electrocardiogra | 1998 |
Potentially fatal interaction between azithromycin and disopyramide.
Topics: Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Azithromycin; Cat-Scratch Disease; Disopyramid | 2000 |
2 trials available for disopyramide and Tachycardia, Ventricular
| Article | Year |
|---|---|
Effects of antiarrhythmic agents on left ventricular function during exercise in patients with chronic left ventricular dysfunction.
Topics: Aged; Anti-Asthmatic Agents; Chronic Disease; Disopyramide; Exercise; Exercise Test; Female; Heart V | 2004 |
Clinical characteristics and EPS-guided therapy in 142 cases of sustained ventricular tachycardia.
Topics: Aged; Anti-Arrhythmia Agents; Catheter Ablation; Combined Modality Therapy; Disopyramide; Electrophy | 1996 |
11 other studies available for disopyramide and Tachycardia, Ventricular
| Article | Year |
|---|---|
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Ca | 2020 |
Theophylline as an adjunct to control malignant ventricular arrhythmia associated with early repolarization.
Topics: Anti-Arrhythmia Agents; Child; Defibrillators, Implantable; Disopyramide; Humans; Male; Quinidine; R | 2018 |
Nifekalant and disopyramide in a patient with short QT syndrome: evaluation of pharmacological effects and electrophysiological properties.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Body Surface Potential Mapping; Disopyramide; Humans; M | 2008 |
Effects of bidisomide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Complexes, Premature; Coronary Disease; Dis | 1995 |
Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Blood Pressure; Coronary Vessels; Disopyramide; Dogs; Dr | 1993 |
Electrical proarrhythmia with procainamide: a new ICD-drug interaction.
Topics: Aged; Defibrillators, Implantable; Disopyramide; Humans; Male; Mexiletine; Procainamide; Tachycardia | 1994 |
Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: comparison with conventional class I drugs.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disease Models, Animal; Disopyrami | 1993 |
Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Disopyramide; Electrocardiography; Humans; | 1996 |
Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Administration S | 1996 |
Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Dose-Response Relationship, | 1997 |
Anisotropic effects of sodium channel blockers on the wavelength for ventricular excitation in dogs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Electr | 2000 |